Vendor, Columbia, MD
Optosurgical, LLC
UEI N5FFBMLQHAJ9, CAGE 8BQW2
1 award and $0 obligated between July 13, 2026 and July 13, 2026, 100% under full and open competition, against 1.0 offers on average where reported.
Industries
NAICS on the awards, by dollars.
| Research and Development in Biotechnology (except Nanobiotechnology)NAICS 541714 | $0 |
How it wins
Awards by competition, set-aside and type.
| Full and Open Competition After Exclusion of Sources | 1 |
| Small Business Set Aside - Total | 1 |
| Definitive Contract | 1 |
Awards
Every award in the window, by dollars obligated.
| Contract | Awarding office | Described as | Obligated |
|---|---|---|---|
| 140D0426C0062Definitive Contract, July 13, 2026, Full and Open Competition After Exclusion of Sources, 1 offers | Ibc Acq SVCS DirectorateDepartmental Offices | SBIR PH II "translation of Novel Biliary Tract-Specific Contrast Agent to Mediate Successful Image-Guided Hepatobiliary Interventions"NAICS 541714, PSC AN13 | $0 |
- Places of performance
- Maryland
- Product and service codes
- AN13 Health R&D Services; Health Care Services; Experimental Development
- Transactions
- 1 across 1 awards